Mode
Text Size
Log in / Sign up
Phase 3 N=302 Randomized Prevention

Enhancing Fitness in Older Pre-diabetic Veterans

Impaired Glucose Tolerance · Obesity · Diabetes

Enrolled (actual)
302
Serious AEs
12.3%
Results posted
Jan 2015
Primary outcome: Primary: Fasting Insulin — 10.26; 10.39 uIU/ml

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Physical Activity Counseling (Behavioral)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
US Department of Veterans Affairs
Primary completion
Mar 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Fasting Insulin
10.26; 10.39
PRIMARY
3 Month Fasting Insulin
10.04; 10.45
PRIMARY
12 Month Fasting Insulin
11.4; 10.28 0.43
PRIMARY
Fasting Glucose
110.51; 110.6
PRIMARY
3 Month Fasting Glucose
106.96; 107.63
PRIMARY
12 Month Fasting Glucose
104.35; 104.38 0.91
SECONDARY
Physical Activity, Endurance
133.6; 112.62 <0.001 sig
SECONDARY
Physical Activity, Endurance
133.6; 112.62 <0.001 sig
SECONDARY
Physical Activity, Endurance
133.6; 112.62 <0.001 sig

Summary

This study targets older adults (ages 60 and over) who are overweight (body mass index 25-40) with impaired fasting glucose (100 - 125). We propose a three-year, randomized controlled clinical trial (n=300) to determine the effect of a one-year physical activity counseling intervention on glucose metabolism and secondary outcomes compared to usual care.

Eligibility Criteria

Inclusion Criteria

  • VA patients followed by the Durham VA Primary Care, Women's Health, and Geriatric clinics
  • Must have had more than one visit to the VA in preceding 12 months
  • Age 60 and over
  • Impaired glucose intolerance documented by recent fasting blood glucose between 100 and 125 mg/dL
  • Body mass index between 25-40 kg/m2
  • Able to walk 10 meters without human assistance (assistive device acceptable)
  • All participants must be assigned a primary care provider and have had more than one visit to the VA in the preceding 12 months

Exclusion Criteria

  • Free of frank diabetes
  • Fasting blood sugar above 125 mg/dL
  • HbA1c > 7%
  • Unstable angina
  • Recent history of ventricular tachycardia
  • Unstable chronic obstructive pulmonary disease (two hospitalizations within the previous 12 months and/or on oxygen)
  • Uncontrolled hypertension (diastolic blood pressure >110 mm/Hg or systolic > 200mm/Hg)
  • Stroke with moderate to severe aphasia
  • Diagnosis of chronic pain which may interfere with their ability to be physically active
  • Diagnosis of unstable mental or behavioral disorder
  • Diagnosis of memory loss or dementia
  • Visual or hearing loss severe enough to interfere with ability to receive telephone counseling and review written materials
  • Active substance abuse
  • A terminal diagnosis
  • Followed by VA for medications only
  • Regularly, vigorously physically active for six months or longer.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00594399). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search